marketcap
Facebook
Twitter
Telegram
Fehler meldenФармсинтез Gewinn / Verlust 2007-2025 | LIFE
Gewinn / Verlust Jährlich Фармсинтез
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue |
380 M | 438 M | 372 M | 291 M | 282 M | 724 M | 661 M | 331 M | 378 M | 245 M | 266 M | 412 M | 275 M | 228 M | 180 M | 173 M |
Cost Of Revenue |
299 M | 277 M | 212 M | 262 M | 251 M | 414 M | 271 M | 168 M | 165 M | 155 M | 147 M | 295 M | 170 M | 155 M | 100 M | 93.5 M |
Gross Profit |
80.8 M | 161 M | 160 M | 28.7 M | 31.2 M | 309 M | 390 M | 163 M | 213 M | 90.3 M | 119 M | 117 M | 106 M | 73.8 M | 79.7 M | 79 M |
Gross Profit Ratio |
0.21 | 0.37 | 0.43 | 0.1 | 0.11 | 0.43 | 0.59 | 0.49 | 0.56 | 0.37 | 0.45 | 0.28 | 0.38 | 0.32 | 0.44 | 0.46 |
General And Administrative Expenses |
19.9 M | 33.8 M | 24.1 M | 158 M | 15.5 M | 306 M | 138 M | 50.7 M | 56.7 M | 41.2 M | - | - | 33.3 M | 31.4 M | 30.1 M | 23.2 M |
Selling And Marketing Expenses |
23.8 M | 53.5 M | 43.9 M | 71.9 M | 19.5 M | 39.1 M | 28 M | 32.6 M | 55.3 M | 18 M | - | 52 M | 30.5 M | 26 M | 28.6 M | 23.5 M |
Selling General And Administrative Expenses |
43.7 M | 87.2 M | 68 M | 246 M | 35 M | 345 M | 166 M | 83.3 M | 112 M | 59.2 M | 144 M | 52 M | 63.7 M | 57.5 M | 58.8 M | 46.7 M |
Other Expenses |
188 M | 189 M | 86.8 M | 1.8 B | -43.4 M | 655 M | 445 M | 434 M | 202 M | 204 M | 16.5 M | -88 M | -13.8 M | -7.13 M | -13.7 M | -7.46 M |
Operating Expenses |
248 M | 330 M | 201 M | 2.05 B | -35.5 M | 1.27 B | 968 M | 711 M | 421 M | 280 M | 301 M | 114 M | 63.7 M | 57.5 M | 58.8 M | 46.7 M |
Cost And Expenses |
547 M | 607 M | 413 M | 2.31 B | 215 M | 1.68 B | 1.24 B | 879 M | 586 M | 435 M | -448 M | 409 M | 233 M | 212 M | 159 M | 140 M |
Interest Expense |
41.3 M | 36.4 M | 29.6 M | - | 5.8 M | 4.54 M | 3.17 M | 2.15 M | 2.12 M | 1.86 M | 4.84 M | 3 M | 1.27 M | 3.03 M | 1.63 M | 139 K |
Depreciation And Amortization |
27.5 M | 32 M | 44.4 M | 25.9 M | 54.6 M | 42.6 M | 71.9 M | 31.7 M | 36.2 M | 22.9 M | 27.3 M | 28 M | -13.6 M | -7.13 M | -13.7 M | -7.46 M |
EBITDA |
-140 M | -647 M | -199 M | -192 M | -213 M | -1.01 B | -613 M | -364 M | -160 M | -119 M | -30 M | 31 M | 28 M | 9.26 M | 7.25 M | 24.9 M |
EBITDA Ratio |
-0.37 | -0.73 | -0.98 | -0.66 | 0.13 | -3.81 | -0.8 | -1.57 | -0.42 | -0.52 | -0.11 | 0.08 | 0.1 | 0.04 | 0.04 | 0.14 |
Operating Income |
-167 M | -169 M | -41.4 M | -2.02 B | 66.7 M | -2.88 B | -616 M | -600 M | -208 M | -180 M | -182 M | 3 M | 42 M | 16.4 M | 21 M | 32.3 M |
Operating Income Ratio |
-0.44 | -0.39 | -0.11 | -6.94 | 0.24 | -3.98 | -0.93 | -1.81 | -0.55 | -0.73 | -0.68 | 0.01 | 0.15 | 0.07 | 0.12 | 0.19 |
Income Before Tax |
-209 M | -733 M | -527 M | -2.03 B | 1.81 M | -2.84 B | -945 M | -398 M | -199 M | -153 M | -62.2 M | 28 M | 27 M | 6.23 M | 5.61 M | 24.7 M |
Income Before Tax Ratio |
-0.55 | -1.67 | -1.42 | -6.97 K | 0.01 | -3.93 | -1.43 | -1.2 | -0.53 | -0.63 | -0.23 | 0.07 | 0.1 | 0.03 | 0.03 | 0.14 |
Income Tax Expense |
-1.22 M | -35.9 M | -2.4 M | 217 M | -58 M | -71.3 M | -34.7 M | -43.5 M | 6.02 M | -6.08 M | -7.65 M | 14 M | 7.98 M | -7.82 M | 3.49 M | 7.87 M |
Net Income Ratio |
-0.55 | -1.59 | -1.41 | -6.22 | 0.21 | -3.49 | -1.36 | -1.07 | -0.54 | -0.6 | -0.2 | 0.03 | 0.07 | 0.06 | 0.01 | 0.1 |
Earnings Per Share, EPS |
-0.69 | -2.32 | -1.74 | -6.02 | 0.21 | -9.13 | -5.92 | -2.34 | -1.43 | -1.37 | -0.77 | 0.05 | 0.06 | 0.11 | 0.02 | 0.14 |
EPS Diluted |
-0.69 | -2.32 | -1.74 | -6.02 | 0.2 | -9.13 | -5.92 | -2.34 | -1.43 | -1.37 | -0.77 | 0.05 | 0.06 | 0.11 | 0.02 | 0.14 |
Weighted Average Shares Outstanding |
301 M | 301 M | 301 M | 301 M | 289 M | 276 M | 152 M | 152 M | 143 M | 108 M | 70.7 M | 301 M | 301 M | 125 M | 125 M | 125 M |
Alle Zahlen in RUB-Währung
Gewinn / Verlust Vierteljährlich Фармсинтез
| 2023-Q2 | 2022-Q4 | 2022-Q2 | 2021-Q4 | 2021-Q2 | 2020-Q4 | 2020-Q2 | 2019-Q4 | 2019-Q2 | 2018-Q4 | 2018-Q2 | 2017-Q4 | 2017-Q2 | 2016-Q4 | 2016-Q2 | 2015-Q4 | 2015-Q2 | 2014-Q4 | 2014-Q2 | 2013-Q4 | 2013-Q2 | 2012-Q4 | 2011-Q4 | 2011-Q2 | 2010-Q4 | 2010-Q2 | 2009-Q4 | 2009-Q2 | 2008-Q4 | 2008-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue |
172 M | 172 M | 208 M | 216 M | 222 M | 229 M | 142 M | 94.3 M | 197 M | 245 M | 104 M | 380 M | 343 M | 468 M | 193 M | 125 M | 247 M | 189 M | 189 M | 260 M | 46.8 M | 133 M | 206 M | 206 M | 138 M | 138 M | 114 M | 114 M | 90 M | 90 M |
Cost Of Revenue |
119 M | 151 M | 148 M | 166 M | 111 M | 133 M | 78.7 M | 147 M | 115 M | 126 M | 138 M | 120 M | 328 M | 15.9 M | 249 M | 155 M | 293 M | 82.5 M | 82.5 M | 237 M | 32.8 M | 73.7 M | 148 M | 148 M | 84.8 M | 84.8 M | 77.3 M | 77.3 M | 50.1 M | 50.1 M |
Gross Profit |
53.5 M | 20.5 M | 60.3 M | 50.5 M | 111 M | 96.4 M | 63.5 M | -52.7 M | 81.4 M | 119 M | -33.6 M | 260 M | 15.3 M | 453 M | -56.5 M | -30 M | -46.6 M | 106 M | 106 M | 22.4 M | 14 M | 59.5 M | 58.5 M | 58.5 M | 52.8 M | 52.8 M | 36.9 M | 36.9 M | 39.9 M | 39.9 M |
Gross Profit Ratio |
0.31 | 0.119 | 0.29 | 0.233 | 0.498 | 0.42 | 0.447 | -0.559 | 0.414 | 0.486 | -0.323 | 0.684 | 0.045 | 0.966 | -0.293 | -0.241 | -0.189 | 0.563 | 0.563 | 0.086 | 0.299 | 0.447 | 0.284 | 0.284 | 0.384 | 0.384 | 0.323 | 0.323 | 0.443 | 0.443 |
General And Administrative Expenses |
90.5 M | 69.5 M | 41.9 M | 41.9 M | 43.7 M | 46.1 M | 39 M | 55.4 M | 103 M | 118 M | 106 M | 243 M | 331 M | 271 M | 67.3 M | 77.8 M | 84.9 M | 28.3 M | 28.3 M | 106 M | 21.4 M | - | - | - | 16.6 M | 16.6 M | 15.7 M | 15.7 M | 15.1 M | 15.1 M |
Selling And Marketing Expenses |
7.81 M | 15.9 M | 11 M | 29.2 M | 10.9 M | 20.3 M | 18.7 M | 18.4 M | 53.5 M | 61.8 M | 98.8 M | 154 M | 55.3 M | 56.6 M | 47.5 M | 72.5 M | 94.8 M | 27.6 M | 27.6 M | 43.3 M | 15.2 M | - | 26 M | 26 M | 15.2 M | 15.2 M | 13 M | 13 M | 14.3 M | 14.3 M |
Selling General And Administrative Expenses |
98.3 M | 89.4 M | 106 M | 102 M | 319 M | 142 M | 115 M | 89.6 M | 156 M | 200 M | 205 M | 423 M | 386 M | 345 M | 115 M | 170 M | 180 M | 56 M | 56 M | 156 M | 39.9 M | 72 M | 26 M | 26 M | 31.9 M | 31.9 M | 28.7 M | 28.7 M | 29.4 M | 29.4 M |
Other Expenses |
69 M | - | -805 K | -11.7 M | -2.04 M | - | - | 1.76 B | 35.7 M | - | - | - | - | - | - | - | - | 101 M | 101 M | - | - | 8.27 M | -44 M | -44 M | -6.92 M | -6.92 M | -3.56 M | -3.56 M | -6.85 M | -6.85 M |
Operating Expenses |
178 M | 162 M | 126 M | 165 M | 324 M | 178 M | 125 M | 1.85 B | 195 M | 265 M | 362 M | 2.63 B | 483 M | 1.88 B | 784 M | 100 M | 234 M | 211 M | 211 M | 115 M | 173 M | 151 M | 57 M | 57 M | 31.9 M | 31.9 M | 28.7 M | 28.7 M | 29.4 M | 29.4 M |
Cost And Expenses |
297 M | 314 M | 273 M | 331 M | 435 M | 311 M | 204 M | 2 B | 311 M | 391 M | 500 M | 2.75 B | 811 M | 1.9 B | 1.03 B | 255 M | 528 M | 293 M | 293 M | 352 M | 205 M | -224 M | 204 M | 204 M | 117 M | 117 M | 106 M | 106 M | 79.5 M | 79.5 M |
Interest Expense |
- | - | 19 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.06 M | 1.06 M | - | - | 2.42 M | 1.5 M | 1.5 M | 634 K | 634 K | 1.52 M | 1.52 M | 817 K | 817 K |
Depreciation And Amortization |
8.23 M | 8.18 M | 11.7 M | 15.9 M | 16 M | 26.3 M | 18.1 M | 419 K | 25.5 M | 27 M | 27.6 M | 21.7 M | 29 M | 34.1 M | 37.8 M | 15.5 M | 16.2 M | 18.1 M | 18.1 M | 20.8 M | 6.76 M | 13.7 M | 14 M | 14 M | -6.82 M | -6.82 M | -3.56 M | -3.56 M | -6.85 M | -6.85 M |
EBITDA |
-38.4 M | -59.3 M | -3.73 M | -442 M | -228 M | -307 M | -90.2 M | -160 M | -32.1 M | 786 M | -1.01 B | -2.59 B | -873 M | -2.62 B | -267 M | -253 M | -265 M | -80.2 M | -80.2 M | -115 M | -22.7 M | -15 M | 15.5 M | 15.5 M | 14 M | 14 M | 4.63 M | 4.63 M | 3.62 M | 3.62 M |
EBITDA Ratio |
-0.223 | -0.345 | -0.258 | -0.457 | -0.888 | -0.241 | -0.305 | -1.69 | -0.163 | 0.354 | -2.11 | -1.38 | -1.28 | -2.73 | 3.97 | -2.03 | -1.07 | -0.425 | -0.425 | -0.444 | -0.486 | -0.113 | 0.075 | 0.075 | 0.102 | 0.102 | 0.041 | 0.041 | 0.04 | 0.04 |
Operating Income |
-125 M | -67.5 M | -65.4 M | -115 M | -213 M | -81.5 M | -61.5 M | -1.91 B | -114 M | 59.9 M | -247 M | -547 M | -468 M | -1.31 B | 727 M | -268 M | -281 M | -104 M | -104 M | -136 M | -29.5 M | -91 M | 1.5 M | 1.5 M | 21 M | 21 M | 8.19 M | 8.19 M | 10.5 M | 10.5 M |
Operating Income Ratio |
-0.723 | -0.393 | -0.315 | -0.531 | -0.96 | -0.355 | -0.433 | -20.2 | -0.578 | 0.244 | -2.37 | -1.44 | -1.36 | -2.8 | 3.77 | -2.16 | -1.14 | -0.551 | -0.551 | -0.525 | -0.63 | -0.683 | 0.007 | 0.007 | 0.152 | 0.152 | 0.072 | 0.072 | 0.116 | 0.116 |
Income Before Tax |
-142 M | -164 M | -34.4 M | -454 M | -262 M | -351 M | -120 M | -1.91 B | -117 M | -41.7 M | -509 M | -1.32 B | -1.52 B | -1.18 B | 488 M | -119 M | -279 M | -99.4 M | -99.4 M | 154 M | -154 M | -31.1 M | 14 M | 14 M | 13.5 M | 13.5 M | 3.11 M | 3.11 M | 2.81 M | 2.81 M |
Income Before Tax Ratio |
-0.822 | -0.956 | -0.165 | -2.1 | -1.18 | -1.53 | -0.843 | -20.3 K | -593 | -0.17 | -4.89 | -3.47 | -4.44 | -2.52 | 2.53 | -0.96 | -1.13 | -0.526 | -0.526 | 0.592 | -3.28 | -0.233 | 0.068 | 0.068 | 0.098 | 0.098 | 0.027 | 0.027 | 0.031 | 0.031 |
Income Tax Expense |
21.8 M | 24.1 M | 22.9 M | -17.1 M | -18.8 M | 20.6 M | -23 M | 141 M | 76.1 M | 10.2 M | 123 M | 53.5 M | 17.8 M | 12.4 M | 24 M | 47.7 M | 4.16 M | 3.01 M | 3.01 M | 1.66 M | 2.21 M | -3.82 M | 7 M | 7 M | 3.99 M | 3.99 M | -3.91 M | -3.91 M | 1.74 M | 1.74 M |
Net Income Ratio |
-0.949 | -0.816 | -0.324 | -2.06 | -1.14 | -1.82 | -0.756 | -18.8 | -0.206 | -0.128 | -3.71 | -2.67 | -4.39 | -2.46 | 2.66 | -0.577 | -1.15 | -0.542 | -0.542 | 0.598 | -3.23 | -0.205 | 0.034 | 0.034 | 0.069 | 0.069 | 0.061 | 0.061 | 0.012 | 0.012 |
Earnings Per Share, EPS |
-0.54 | -0.48 | -0.22 | -1.48 | -0.84 | -1.39 | -0.36 | -6.1 | -0.13 | -0.107 | -1.28 | -4.04 | -5 | -7.6 | 3.38 | -0.48 | -1.88 | -0.715 | -0.715 | 1.26 | -1.64 | -0.38 | 0.023 | 0.023 | 0.032 | 0.032 | 0.055 | 0.055 | 0.009 | 0.009 |
EPS Diluted |
-0.54 | -0.48 | -0.22 | -1.48 | -0.84 | -1.39 | -0.36 | -6.1 | -0.13 | -0.105 | -1.28 | -4.04 | -5 | -7.6 | 3.38 | -0.48 | -1.88 | -0.715 | -0.715 | 1.26 | -1.64 | -0.38 | 0.023 | 0.023 | 0.032 | 0.032 | 0.055 | 0.055 | 0.009 | 0.009 |
Weighted Average Shares Outstanding |
303 M | 295 M | 301 M | 301 M | 301 M | 301 M | 298 M | 290 M | 312 M | 294 M | 302 M | 251 M | 301 M | 152 M | 152 M | 152 M | 151 M | 143 M | 143 M | 123 M | 92.5 M | 70.7 M | 301 M | 301 M | 301 M | 301 M | 125 M | 125 M | 125 M | 125 M |
Alle Zahlen in RUB-Währung